1-3 of 3
clonal hematopoiesis
Close
Sort by
Journal Articles

Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy

Peter G. Miller, Adam S. Sperling, Elliott J. Brea, Mark B. Leick, Geoffrey G. Fell, Max Jan, Satyen H. Gohil, Yu-Tzu Tai, Nikhil C. Munshi, Catherine J. Wu, Donna S. Neuberg, Marcela V. Maus, Caron Jacobson, Christopher J. Gibson, Benjamin L. Ebert
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2982–2986.
https://doi.org/10.1182/bloodadvances.2021004554
Published: 2021
Includes: Supplemental data
Journal Articles

Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years

Clinical Trials & Observations
Isabelle A. van Zeventer, Jonas B. Salzbrunn, Aniek O. de Graaf, Bert A. van der Reijden, H. Marike Boezen, Judith M. Vonk, Pim van der Harst, Jan Jacob Schuringa, Joop H. Jansen, Gerwin Huls
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2115–2122.
https://doi.org/10.1182/bloodadvances.2020004062
Published: 2021
Includes: Supplemental data
Journal Articles

Precocious clonal hematopoiesis in Down syndrome is accompanied by immune dysregulation

Clinical Trials & Observations
L. Alexander Liggett, Matthew D. Galbraith, Keith P. Smith, Kelly D. Sullivan, Ross E. Granrath, Belinda Enriquez-Estrada, Kohl T. Kinning, Jessica R. Shaw, Angela L. Rachubinski, Joaquin M. Espinosa, James DeGregori
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1791–1796.
https://doi.org/10.1182/bloodadvances.2020003858
Published: 2021
Includes: Supplemental data